Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Telehealth Is Here to Stay: But How Do You Find the Right Markets?

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.   There’s no denying the importance of technology in healthcare; in fact, it became even…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

There’s no denying the importance of technology in healthcare; in fact, it became even more critical in the last year. With so many opportunities to improve care delivery, it’s about getting the right products to market. That’s the focus on Aaron Call, Founder of Jaunt. He joined I Don’t Care and host Kevin Stevenson to talk about this dynamic. Call is a long-time med-tech startup pioneer. Jaunt connects businesses with investors through data-backed insights and models.

“We work on early-stage companies and focusing on what can be improved for healthcare and then how to commercialize,” Call explained.

“It amazed me. There were so many economic benefits. It was the payers holding it up in many ways, and the pandemic adjusted this.” – Aaron Call

While telehealth is certainly the buzziest tech in the space, it’s not the only field Jaunt specializes in, but Call and his team worked with telemed platforms differentiate.

“Years ago, we saw that most companies were just SaaS products, not much different than Zoom. We helped a client realize there was a need for much more robust tools for such a system,” Call noted.

Call also noted the U.S. had little adoption pre-pandemic. “It amazed me. There were so many economic benefits. It was the payers holding it up in many ways, and the pandemic adjusted this.”

Jaunt realized that what they were doing for companies with market analysis and commercialization strategies was what investors were seeking in due diligence. “We’re serving up information from a third party that startups can use to go to investors, and the investors know us as a trusted source.”

Call said that the pandemic didn’t dry up investment, as they first expected. What it did do is change approaches to commercialization, sales models, and predictive market analytics.

He also shared what’s exciting him in the space right now. “Personalized health with data and tech behind it is exciting. Digital health that can help change behaviors and improve life is also big right now.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel →

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512